Company Filing History:
1 out of 560 
1 out of 512 
1 out of 20 
Years Active: 2025
Title: Sascha P Haubner: Innovator in Chimeric Receptor Technology
Introduction
Sascha P Haubner is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of chimeric receptors that target specific proteins involved in cancer treatment.
Latest Patents
Haubner holds a patent for "Chimeric receptors targeting ADGRE2 and/or CLEC12A and uses thereof." This patent describes innovative chimeric receptors that specifically target ADGRE2 and CLEC12A. The disclosed subject matter includes cells that comprise these targeted chimeric receptors, which can be utilized for treating tumors, such as acute myeloid leukemia (AML). He has 1 patent to his name.
Career Highlights
Throughout his career, Haubner has worked with prestigious institutions, including Memorial Sloan Kettering Cancer Center and the Sloan Kettering Institute for Cancer Research. His work has focused on advancing cancer therapies through innovative receptor technologies.
Collaborations
Haubner has collaborated with esteemed colleagues in the field, including Michel Sadelain and Jorge Mansilla-Soto. These collaborations have contributed to the advancement of research in cancer treatment.
Conclusion
Sascha P Haubner is a pioneering inventor whose work in chimeric receptor technology holds promise for improving cancer therapies. His contributions to the field are significant and continue to influence ongoing research and development.